These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 18647300)

  • 1. Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine.
    Shabsigh R; Patrick DL; Rowland DL; Bull SA; Tesfaye F; Rothman M
    BJU Int; 2008 Sep; 102(7):824-8. PubMed ID: 18647300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment benefit of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial.
    Kaufman JM; Rosen RC; Mudumbi RV; Tesfaye F; Hashmonay R; Rivas D
    BJU Int; 2009 Mar; 103(5):651-8. PubMed ID: 19021601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of the patient-reported Clinical Global Impression of Change as a measure of treatment response in men with premature ejaculation.
    Althof SE; Brock GB; Rosen RC; Rowland DL; Aquilina JW; Rothman M; Tesfaye F; Bull S
    J Sex Med; 2010 Jun; 7(6):2243-2252. PubMed ID: 20367770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine.
    McMahon C; Kim SW; Park NC; Chang CP; Rivas D; Tesfaye F; Rothman M; Aquilina J;
    J Sex Med; 2010 Jan; 7(1 Pt 1):256-68. PubMed ID: 19878447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries.
    Buvat J; Tesfaye F; Rothman M; Rivas DA; Giuliano F
    Eur Urol; 2009 Apr; 55(4):957-67. PubMed ID: 19195772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study.
    McMahon CG; Giuliano F; Dean J; Hellstrom WJ; Bull S; Tesfaye F; Sharma O; Rivas DA; Aquilina JW
    J Sex Med; 2013 Sep; 10(9):2312-25. PubMed ID: 23845016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials.
    McMahon CG; Althof SE; Kaufman JM; Buvat J; Levine SB; Aquilina JW; Tesfaye F; Rothman M; Rivas DA; Porst H
    J Sex Med; 2011 Feb; 8(2):524-39. PubMed ID: 21059176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dapoxetine: in premature ejaculation.
    Hoy SM; Scott LJ
    Drugs; 2010 Jul; 70(11):1433-43. PubMed ID: 20614950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials.
    Pryor JL; Althof SE; Steidle C; Rosen RC; Hellstrom WJ; Shabsigh R; Miloslavsky M; Kell S;
    Lancet; 2006 Sep; 368(9539):929-37. PubMed ID: 16962882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: integrated analyses of two phase 3 dapoxetine trials.
    Porst H; McMahon CG; Althof SE; Sharlip I; Bull S; Aquilina JW; Tesfaye F; Rivas DA
    J Sex Med; 2010 Jun; 7(6):2231-2242. PubMed ID: 20412423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Premature Ejaculation Profile: validation of self-reported outcome measures for research and practice.
    Patrick DL; Giuliano F; Ho KF; Gagnon DD; McNulty P; Rothman M
    BJU Int; 2009 Feb; 103(3):358-64. PubMed ID: 18793300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study.
    Dinsmore WW; Wyllie MG
    BJU Int; 2009 Apr; 103(7):940-9. PubMed ID: 19245438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective serotonin re-uptake inhibitors for premature ejaculation in adult men.
    Sathianathen NJ; Hwang EC; Mian R; Bodie JA; Soubra A; Lyon JA; Sultan S; Dahm P
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012799. PubMed ID: 33745183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of dapoxetine versus paroxetine in patients with premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study.
    Safarinejad MR
    Clin Neuropharmacol; 2006; 29(5):243-52. PubMed ID: 16960468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dapoxetine for premature ejaculation: an updated meta-analysis of randomized controlled trials.
    Li J; Yuan H; Bai Y; Pu C; Tang Y; Dong Q; Wei Q; Han P
    Clin Ther; 2014 Dec; 36(12):2003-2014. PubMed ID: 25438723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation.
    Hutchinson K; Cruickshank K; Wylie K
    Drug Saf; 2012 May; 35(5):359-72. PubMed ID: 22452563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premature ejaculation and pharmaceutical company-based medicine: the dapoxetine case.
    Waldinger MD; Schweitzer DH
    J Sex Med; 2008 Apr; 5(4):966-997. PubMed ID: 18371047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dapoxetine for premature ejaculation.
    McMahon CG
    Expert Opin Pharmacother; 2010 Jul; 11(10):1741-52. PubMed ID: 20540653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral agents for the treatment of premature ejaculation: review of efficacy and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong premature ejaculation.
    McMahon CG; Porst H
    J Sex Med; 2011 Oct; 8(10):2707-25. PubMed ID: 21771283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of dapoxetine in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study.
    Safarinejad MR
    Neuropsychopharmacology; 2008 May; 33(6):1259-65. PubMed ID: 17625501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.